If you’re hunting for the best crypto to buy now, especially under $1, many eyes are turning toward undervalued crypto […] The post VeChain Price Prediction: What is The Best Crypto To Buy Under $1 This Week? appeared first on Coindoo.If you’re hunting for the best crypto to buy now, especially under $1, many eyes are turning toward undervalued crypto […] The post VeChain Price Prediction: What is The Best Crypto To Buy Under $1 This Week? appeared first on Coindoo.

VeChain Price Prediction: What is The Best Crypto To Buy Under $1 This Week?

2025/10/13 05:15
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

If you’re hunting for the best crypto to buy now, especially under $1, many eyes are turning toward undervalued crypto projects with real use cases and strong narratives. But is VET really the pick this week, or is something newer like Remittix capturing the spotlight?

VeChain Price Prediction: Still a Top Crypto Under $1?

VeChain has been around long enough to earn respect. It’s often cited in lists of ‘top altcoins under $1’ thanks to its real-world partnerships, enterprise focus, and dual-token model (VET + VTHO).

However, it was not exempt from the recent crypto market crash and is down 23% over the past 24 hours. Some forecasts for 2025 place VET in a range of $0.021–$0.025 if the market recovers.

However, longer-term bull scenarios suggest more aggressive targets, like $0.17 in 2026 and $0.33 by 2030, but these require exceptional growth and adoption. On technicals, VET’s RSI is neutral; the coin appears to be waiting for a catalyst.

Remittix (RTX): The New High-Growth Altcoin People Are Calling XRP 2.0

Remittix, a DeFi / PayFi hybrid project, is fast becoming one of the best projects to invest in. Early buyers are already seeing huge gains in presale rounds. The recent crash shows that projects like Remittix offer the most stable investment option.

It is aiming to bridge the gap between crypto and banking by enabling crypto-to-bank transfers across 30+ countries, with real-time FX conversion, and multi-chain compatibility. It’s being positioned as a cross-chain DeFi project built for actual payments rather than speculation.

While VeChain has enterprise roots, it is subject to changing market conditions which are currently unfavorable. Remittix is in the early stage crypto investment zone with a stable upside. For some, this is a chance to back the next 10x or 20x breakout.

Why Remittix Is Gaining Traction

  • Global Reach: enables sending crypto directly to bank accounts in 30+ countries
  • Real-World Utility: built for payments, not just trading
  • Certified Audit: top marks from CertiK on pre-launch contract
  • Business API & Merchant Tools: enabling liquidity from real businesses
  • Strong Fundraising: tens of millions raised already, signaling high growth crypto narrative

Given all this, Remittix is being heavily marketed and perceived as XRP 2.0 — a centralized exchanges promise, cross-chain ambition, and blazing early traction all baked into one new altcoin.

Remittix $250,000 Giveaway & Referral Launch: Jump In Now or Miss Out

Now for the final push: Remittix isn’t just riding hype, it’s dangling urgency in front of you. There’s a $250,000 community giveaway live, with over 300,000 entries already. The project reports more than 40,000 unique holders. And now, Remittix has launched a referral program that rewards you.

If you believe Remittix isn’t just hype but a high growth crypto play that may disrupt legacy payments, now’s your moment. This giveaway + referral push is crafted to ignite FOMO and accelerate adoption. Don’t watch from the sidelines while others lock in gains.

Discover the future of PayFi with Remittix by checking out their project here:

Website: https://remittix.io    

Socials: https://linktr.ee/remittix    

$250, 000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway 


This publication is sponsored. Coindoo does not endorse or assume responsibility for the content, accuracy, quality, advertising, products, or any other materials on this page. Readers are encouraged to conduct their own research before engaging in any cryptocurrency-related actions. Coindoo will not be liable, directly or indirectly, for any damages or losses resulting from the use of or reliance on any content, goods, or services mentioned. Always do your own research.

The post VeChain Price Prediction: What is The Best Crypto To Buy Under $1 This Week? appeared first on Coindoo.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09